Skip to main content
ANAB
NASDAQ Life Sciences

Officer Dennis Mulroy Files Intent to Sell Additional Shares, Continuing Recent Distribution Trend

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$57.6
Mkt Cap
$1.677B
52W Low
$11.402
52W High
$72.36
52W Position info
405% above low
Off High info
20% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

ANAB has more than doubled off its 52-week low of $11.402.

Summary

Officer Dennis Mulroy has filed to sell additional shares, extending a pattern of significant stock sales totaling over $17 million in the last three months.


Key Events · Ownership and Investor Activity · ANAB

  • Officer Files Intent to Sell

    Officer Dennis Mulroy has filed a Form 144 indicating intent to sell 1,265 shares of common stock, valued at approximately $75,900.

  • Continuation of Significant Selling Trend

    This filing is part of an ongoing pattern, with Mulroy having sold a cumulative total of over $17.29 million in company stock over the past three months, representing a significant distribution of shares.


Analysis · ANAB · Life Sciences

This Form 144 indicates Officer Dennis Mulroy's intent to sell 1,265 shares, valued at approximately $75,900. While this specific proposed sale is modest, the filing also reports that Mulroy has sold over $17 million worth of company stock in the past three months. This ongoing pattern of significant share distribution by an officer, following the company's recent spin-off and share repurchase program announcement, suggests a continued reduction in insider exposure.

How filings like this one have moved

In the 30 days to Sep 30, 2026, 34.7% of the 1013 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.50%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ANAB was trading at $57.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $11.40 to $72.36. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ANAB - Latest Insights

ANAB
Sep 28, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $50.85
Real-time Price: $50.86 info
Change: +$0.0100 (+0.02%) info
Market Cap: $1.52B info
ANAB
Sep 21, 2026, 4:23 PM EDT
Filing Type: 10-KT
Importance Score:
8
Price at Filing: $55.99
Real-time Price: $50.86 info
Change: -$5.13 (-9%) info
Market Cap: $1.52B info
ANAB
Sep 21, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $55.99
Real-time Price: $50.86 info
Change: -$5.13 (-9%) info
Market Cap: $1.52B info
ANAB
Sep 21, 2026, 4:15 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $55.99
Real-time Price: $50.86 info
Change: -$5.13 (-9%) info
Market Cap: $1.52B info
ANAB
Jun 29, 2026, 4:15 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $65.97
Real-time Price: $50.86 info
Change: -$15.11 (-23%) info
Market Cap: $1.52B info